| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |